Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 266, P. 155778 - 155778
Published: Dec. 17, 2024
Language: Английский
Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 266, P. 155778 - 155778
Published: Dec. 17, 2024
Language: Английский
Experimental & Molecular Medicine, Journal Year: 2024, Volume and Issue: 56(6), P. 1235 - 1249
Published: June 14, 2024
It is apparent that various functional units within the cellular machinery are derived from RNAs. The evolution of sequencing techniques has resulted in significant insights into approaches for transcriptome studies. Organisms utilize RNA to govern systems, and a heterogeneous class RNAs involved regulatory functions. In particular, increasingly recognized participate intricately functioning across almost all levels biological systems. These systems include those mediating chromatin arrangement, transcription, suborganelle stabilization, posttranscriptional modifications. Any exhibiting activity can be termed typically represented by noncoding RNAs, which constitute substantial portion genome. function based on principle structural changes through cis and/or trans regulation facilitate mutual RNA‒RNA, RNA‒DNA, RNA‒protein interactions. not been clearly elucidated whether identified deep actually anticipated mechanisms. This review addresses dominant properties at layers covers activities, dynamics, modifications, associated molecules, further challenges related therapeutics learning.
Language: Английский
Citations
9Cells, Journal Year: 2025, Volume and Issue: 14(3), P. 227 - 227
Published: Feb. 5, 2025
Long non-coding RNAs (lncRNAs) are a class of RNA molecules with transcripts longer than 200 bp, which were initially thought to be noise from genomic transcription without biological function. However, since the discovery H19 in 1980 and Xist 1990, increasing evidence has shown that lncRNAs regulate gene expression at epigenetic, transcriptional, post-transcriptional levels through specific regulatory actions involved development cancer other diseases. Despite many being expressed lower those protein-coding genes less sequence conservation across species, have become an intense area research. They exert diverse functions such as inducing chromatin remodeling, recruiting transcriptional machinery, acting competitive endogenous for microRNAs, modulating protein–protein interactions. Epithelial–mesenchymal transition (EMT) is developmental process, associated embryonic development, wound healing, progression. In context oncogenesis, EMT program transiently activated confers migratory/invasive stem cell (CSC) properties tumor cells, crucial malignant progression, metastasis, therapeutic resistance. Accumulating revealed play roles regulation epithelial/mesenchymal plasticity (EMP) stemness. Here, we summarize emerging molecular mechanisms regulating EMP their effects on initiation progression CSCs. We also discuss potential diagnostic prognostic biomarkers targets.
Language: Английский
Citations
1Frontiers in Molecular Biosciences, Journal Year: 2024, Volume and Issue: 11
Published: June 3, 2024
Leading anti-tumour therapeutic strategies typically involve surgery and radiotherapy for locally advanced (non-metastatic) cancers, while hormone therapy, chemotherapy, molecular targeted therapy are the current treatment options metastatic cancer. Despite initially high sensitivity rate to anticancer therapies, a large number of patients develop resistance, leading poor prognosis. The mechanisms related drug resistance highly complex, long non-coding RNAs appear play crucial role in these processes. Among these, lncRNA homeobox transcript antisense intergenic RNA (HOTAIR), widely implicated cancer initiation progression, likewise plays significant resistance. It can modulate cell activities such as proliferation, apoptosis, hypoxia, autophagy, well epithelial-mesenchymal transition, thereby contributing development resistant tumour cells. In this manuscript, we describe different antitumor which HOTAIR is involved suggest its potential predictive biomarker management patients.
Language: Английский
Citations
5Journal of Translational Medicine, Journal Year: 2025, Volume and Issue: 23(1)
Published: Feb. 26, 2025
Language: Английский
Citations
0International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 142824 - 142824
Published: April 1, 2025
Language: Английский
Citations
0Oncogenesis, Journal Year: 2025, Volume and Issue: 14(1)
Published: April 7, 2025
Language: Английский
Citations
0Gene, Journal Year: 2024, Volume and Issue: 940, P. 149180 - 149180
Published: Dec. 19, 2024
Language: Английский
Citations
2Advances in Clinical Medicine, Journal Year: 2024, Volume and Issue: 14(10), P. 1120 - 1129
Published: Jan. 1, 2024
Language: Английский
Citations
0Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 266, P. 155778 - 155778
Published: Dec. 17, 2024
Language: Английский
Citations
0